Hong Kong Stock Movement Update: ILUVATAR COREX surges 21.61%, SHANGSHAN GOLD plummets 25%

The market overview of Hong Kong stocks in the past hour shows significant fluctuations in market sentiment, with a strong divergence in capital flows. Technology stocks and pharmaceutical stocks have become hotspots for capital chasing, especially the strong performance of ILUVATAR COREX and Jingwei TianDi, which has attracted considerable attention from short-term funds. Meanwhile, gold-related stocks such as SHANGSHAN GOLD have encountered sharp declines, indicating a weakening preference for safe-haven assets in the market. Overall, the short-term enthusiasm is rapidly switching between the technology and pharmaceutical sectors, with large fluctuations and active investor sentiment. The most notable stock in the past hour is ILUVATAR COREX, which has performed impressively, with an increase of 21.61%. Under strong market demand, the pace of its stock price has clearly accelerated, attracting a large influx of short-term funds. The strong rebound of this stock seems to have invigorated the entire technology sector, creating a positive driving effect. Strong stocks: 1. Jingwei TianDi: up 20.27%, with increased market attention on its technological innovations and noticeable capital inflow. 2. Haixi New Drug: up 13.47%, performing outstandingly in the pharmaceutical sector, with heightened market expectations for its new products. 3. ILUVATAR COREX: up 21.61%, with active participation from short-term funds driving its stock price up rapidly and boosting market sentiment. 4. Other technology stocks are also being driven, showing overall active performance and enhanced capital liquidity. Stocks under pressure: 1. SHANGSHAN GOLD: down 25.00%, as the market's demand for gold as a safe haven weakens, leading to a significant decline in its stock price